You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 14, 2025

CLINICAL TRIALS PROFILE FOR SODIUM ACETATE ANHYDROUS


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for Sodium Acetate Anhydrous

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00283387 ↗ Efficacy of Betaine for Reduction of Urine Oxalate in Patients With Type 1 Primary Hyperoxaluria Completed National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Phase 2 2007-02-01 The aim of this study is to assess the efficacy and safety of betaine in reducing urine oxalate excretion of Type 1 Primary Hyperoxaluria (PHI) patients. Hypothesis: Betaine will effectively reduce urine oxalate excretion in Primary Hyperoxaluria Type I patients.
NCT00283387 ↗ Efficacy of Betaine for Reduction of Urine Oxalate in Patients With Type 1 Primary Hyperoxaluria Completed Orphan Europe Phase 2 2007-02-01 The aim of this study is to assess the efficacy and safety of betaine in reducing urine oxalate excretion of Type 1 Primary Hyperoxaluria (PHI) patients. Hypothesis: Betaine will effectively reduce urine oxalate excretion in Primary Hyperoxaluria Type I patients.
NCT00283387 ↗ Efficacy of Betaine for Reduction of Urine Oxalate in Patients With Type 1 Primary Hyperoxaluria Completed Mayo Clinic Phase 2 2007-02-01 The aim of this study is to assess the efficacy and safety of betaine in reducing urine oxalate excretion of Type 1 Primary Hyperoxaluria (PHI) patients. Hypothesis: Betaine will effectively reduce urine oxalate excretion in Primary Hyperoxaluria Type I patients.
NCT00302289 ↗ B181: Stimulation of Thermogenesis by Bio-Active Food Ingredients Completed Science, Toxicology & Technology, San Francisco, California Phase 1 2000-01-01 The primary aim was to measure the effect of green tea extract, tyrosine and caffeine on energy expenditure, appetite ratings and spontaneous energy intake together with recording of side effects in healthy normal weight subjects.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Sodium Acetate Anhydrous

Condition Name

Condition Name for Sodium Acetate Anhydrous
Intervention Trials
Healthy 4
Pachyonychia Congenita 2
Early-Stage Breast Carcinoma 1
Parkinson's Disease 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Sodium Acetate Anhydrous
Intervention Trials
Pachyonychia Congenita 2
Nails, Malformed 2
Nervous System Neoplasms 1
Hepatic Insufficiency 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Sodium Acetate Anhydrous

Trials by Country

Trials by Country for Sodium Acetate Anhydrous
Location Trials
United States 27
Canada 3
Spain 3
United Kingdom 2
Russian Federation 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Sodium Acetate Anhydrous
Location Trials
California 5
Minnesota 4
Utah 2
Florida 2
Connecticut 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Sodium Acetate Anhydrous

Clinical Trial Phase

Clinical Trial Phase for Sodium Acetate Anhydrous
Clinical Trial Phase Trials
Phase 4 4
Phase 3 4
Phase 2/Phase 3 2
[disabled in preview] 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Sodium Acetate Anhydrous
Clinical Trial Phase Trials
Completed 15
Not yet recruiting 5
Recruiting 4
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Sodium Acetate Anhydrous

Sponsor Name

Sponsor Name for Sodium Acetate Anhydrous
Sponsor Trials
National Cancer Institute (NCI) 3
Mayo Clinic 2
Ranbaxy Laboratories Limited 2
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Sodium Acetate Anhydrous
Sponsor Trials
Other 20
Industry 17
NIH 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sodium Acetate Anhydrous: Clinical Trials, Market Analysis, and Projections

Last updated: January 7, 2025

Introduction to Sodium Acetate Anhydrous

Sodium acetate anhydrous is a versatile chemical compound with a wide range of applications, including medical, pharmaceutical, and industrial uses. This article will delve into the current clinical trials, market analysis, and future projections for sodium acetate anhydrous.

Clinical Trials: Focus on Medical Applications

Prevention of Metabolic Acidosis in Preterm Neonates

One significant clinical trial currently underway involves the use of sodium acetate in parenteral nutrition (PN) to prevent and treat metabolic acidosis in preterm neonates. Conducted at the Aga Khan University Hospital in Pakistan, this phase III randomized controlled trial compares the efficacy of sodium acetate versus sodium chloride in neonatal PN.

  • Objective: To determine if the addition of sodium acetate in PN reduces the incidence of metabolic acidosis and associated comorbidities in preterm neonates, and to establish optimal dosing guidelines[1].
  • Methodology: The trial involves two groups: one receiving sodium acetate in PN and the other receiving sodium chloride. The study tracks key outcomes such as pH levels, base excess, and clinical outcomes over the first 28 days of life.
  • Significance: This trial could provide crucial insights into the prevention and treatment of metabolic acidosis, a common complication in preterm neonates, and potentially improve neonatal care standards.

Market Analysis

Global Market Size and Growth

The global sodium acetate market, including both trihydrate and anhydrous forms, has been experiencing steady growth. As of 2023, the market was valued at approximately $118.9 million and is projected to grow at a CAGR of 5.8% to reach $178.4 million by 2030[5].

Key End-Use Industries

Sodium acetate anhydrous is utilized in various industries, with the medical and pharmaceutical sectors being among the most significant.

  • Medical & Pharmaceuticals: It is used as an ingredient in diuretics, expectorants, and systemic alkalizers. Additionally, it is employed in renal dialysis solutions. The growing healthcare expenditure and increasing awareness in consumer groups are driving the demand in this sector[2][5].
  • Other Industries: Leather tanning, detergents, photography, electronics, and animal feeds are other notable end-use industries for sodium acetate anhydrous[2].

Regional Market Dynamics

The market for sodium acetate anhydrous is geographically diverse, with Asia Pacific and North America being the leading consumers.

  • Asia Pacific: This region emerged as the largest consumer in 2013 and continues to drive market growth due to high healthcare expenditure and consumer awareness[2].
  • North America: Following closely behind Asia Pacific, North America also contributes significantly to the market, driven by similar factors[2].

Market Drivers and Challenges

Drivers

  • Growing Pharmaceutical Industry: The expanding pharmaceutical sector, particularly in Asia Pacific and North America, is a major driver for the sodium acetate anhydrous market. Increasing demand for pharmaceutical products that use sodium acetate as an ingredient is fueling market growth[5].
  • Diverse Applications: The versatility of sodium acetate anhydrous in various industries ensures a steady demand across different sectors[2].

Challenges

  • Availability of Substitutes: The presence of numerous substitutes, especially in food and pharmaceutical applications, poses a challenge to the market growth of sodium acetate anhydrous[2].
  • COVID-19 Impact: The COVID-19 pandemic had an adverse impact on the market due to shutdowns of manufacturing units and strict regulatory measures. However, the market is expected to recover as industries adapt to new operational norms[5].

Future Projections

Market Growth Prospects

The sodium acetate anhydrous market is expected to continue its moderate growth trajectory. Here are some key projections:

  • Market Size: The global market is projected to reach $178.4 million by 2030, growing at a CAGR of 5.8% from 2023 to 2030[5].
  • Emerging Opportunities: Novel applications of sodium acetate anhydrous are expected to provide new opportunities for market growth in the coming years. This includes potential new uses in medical and industrial sectors[3].

Regional Expansion

The market is likely to see significant growth in regions with high healthcare expenditure and consumer awareness. Asia Pacific and North America will continue to be key drivers, while Europe and other regions are expected to grow at a significant rate as well[2].

Key Takeaways

  • Clinical Trials: Ongoing clinical trials, such as the one at Aga Khan University Hospital, are exploring the efficacy of sodium acetate anhydrous in preventing metabolic acidosis in preterm neonates.
  • Market Growth: The global sodium acetate anhydrous market is valued at $118.9 million as of 2023 and is projected to grow to $178.4 million by 2030.
  • Key Industries: Medical and pharmaceutical sectors are major drivers of the market, with other industries like leather tanning and detergents also contributing significantly.
  • Regional Dynamics: Asia Pacific and North America are the leading consumers, with Europe and other regions expected to grow significantly.

FAQs

Q: What is the primary focus of the clinical trial involving sodium acetate anhydrous in preterm neonates?

A: The primary focus is to determine if the addition of sodium acetate in parenteral nutrition reduces the incidence of metabolic acidosis and associated comorbidities in preterm neonates[1].

Q: What are the major end-use industries for sodium acetate anhydrous?

A: The major end-use industries include medical and pharmaceuticals, leather tanning, detergents, photography, and electronics[2].

Q: How has the COVID-19 pandemic impacted the sodium acetate anhydrous market?

A: The pandemic had an adverse impact due to shutdowns of manufacturing units and strict regulatory measures, but the market is expected to recover as industries adapt to new norms[5].

Q: What is the projected market size of sodium acetate anhydrous by 2030?

A: The market is projected to reach $178.4 million by 2030, growing at a CAGR of 5.8% from 2023 to 2030[5].

Q: Which regions are expected to drive the growth of the sodium acetate anhydrous market?

A: Asia Pacific and North America are expected to be the leading drivers, with Europe and other regions also showing significant growth potential[2].

Sources

  1. CenterWatch, "Prevention of Metabolic Acidosis in Preterm Neonates by Replacing Sodium Chloride with Sodium Acetate in Parenteral Nutrition".
  2. Transparency Market Research, "Sodium Acetate Trihydrate and Sodium Acetate Anhydrous Market".
  3. OpenPR, "Sodium Acetate Market: Statistical Forecast, Growth Insights".
  4. PubMed, "Effect of Saline vs Gluconate/Acetate-Buffered Solution vs Lactate-Buffered Solution in Critically Ill Children".
  5. Coherent Market Insights, "Sodium Acetate Trihydrate & Sodium Acetate Anhydrous Market".

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.